Â÷¼¼´ë ½ÃÄö½Ì(NGS) ½ÃÀå ºÐ¼® ¹× ¿¹Ãø(-2033³â) : À¯Çü, Á¦Ç°, ¼­ºñ½º, ±â¼ú, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, ±¸¼º¿ä¼Ò, ÇÁ·Î¼¼½º, ±â´É¼ºº°
Next Generation Sequencing Market Analysis and Forecast to 2033: Type, Product, Services, Technology, Application, End User, Component, Process, Functionality
»óǰÄÚµå : 1598643
¸®¼­Ä¡»ç : Global Insight Services LLC
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 305 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,750 £Ü 6,503,000
Single User License help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇϸç, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 5,750 £Ü 7,872,000
Site License help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷(±¹°¡)ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,750 £Ü 9,241,000
Enterprise License help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ Àü ¼¼°è ¸ðµçºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è Â÷¼¼´ë ½ÃÄö½Ì(NGS) ½ÃÀå ±Ô¸ð´Â 2023³â 145¾ï ´Þ·¯¿¡¼­ 2033³â 415¾ï ´Þ·¯·Î ¿¬Æò±Õ 11.1% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ½ÃÀå¿¡´Â ½Å¼ÓÇϰí Á¤È®ÇÑ DNA/RNA ºÐ¼®À» °¡´ÉÇÏ°Ô Çϴ ÷´Ü À¯Àüü ¿°±â¼­¿­ ºÐ¼® ±â¼úÀÌ Æ÷ÇԵ˴ϴÙ. NGS ±â¼úÀº º¹ÀâÇÑ À¯Àü¼º Áúȯ, Á¾¾ç ¹× °¨¿°¼º ÁúȯÀ» ÀÌÇØÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇϸç, Çõ½ÅÀ» ÃËÁøÇϰí ÀÇ·á ¹× »ý¸í°úÇÐÀ» Çõ½ÅÀûÀ¸·Î º¯È­½ÃŰ´Â ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â µ¥ ÀÖ¾î Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÇ·á¿Í »ý¸í°úÇп¡ º¯È­¸¦ °¡Á®¿Ã ¼ö ÀÖ´Â ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

À¯Àüü ¿¬±¸¿Í ¸ÂÃãÇü ÀÇ·áÀÇ ¹ßÀü¿¡ ÈûÀÔ¾î ½ÃÀåÀÌ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ºÎ¹® Áß ½Ã¾à ¹× ŰƮ¸¦ Æ÷ÇÔÇÑ ¼Ò¸ðǰ ÇÏÀ§ ºÎ¹®Àº ½ÃÄö½Ì ÇÁ·Î¼¼½ºÀÇ ¹Ýº¹ÀûÀÎ »ç¿ë°ú Çʿ伺À¸·Î ÀÎÇØ °¡Àå ³ôÀº ¼º°ú¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ½ÃÄö½Ì ¼­ºñ½º ºÎ¹®Àº Àü¹® ¼­ºñ½º Á¦°ø¾÷ü¿¡ ½ÃÄö½Ì ¾÷¹«¸¦ ¾Æ¿ô¼Ò½ÌÇÏ´Â »ç·Ê°¡ Áõ°¡ÇÔ¿¡ µû¶ó µÎ ¹øÂ°·Î ³ôÀº ½ÇÀûÀ» ±â·ÏÇÑ ÇÏÀ§ ºÎ¹®À¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. Áö¿ªº°·Î´Â ºÏ¹Ì°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ÀÇ·á ÀÎÇÁ¶ó°¡ Àß ±¸ÃàµÇ¾î ÀÖ°í À¯Àüü ¿¬±¸¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. À¯·´Àº Á¤ºÎÀÇ Áö¿ø Á¤Ã¥°ú Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ µÎ ¹øÂ°·Î À¯¸®ÇÑ Áö¿ªÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ±¹°¡º°·Î´Â ¹Ì±¹ÀÌ ¼±µÎ¸¦ ´Þ¸®°í ÀÖÁö¸¸, Áß±¹Àº »ý¸í°øÇÐ »ê¾÷ÀÇ È®Àå°ú Á¤ºÎÀÇ À¯Àüü ¿¬±¸ ÀÚ±Ý Áö¿øÀ¸·Î ºü¸£°Ô Ãß°ÝÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ªÇаü°è´Â ÀÇ·á ¹× ¿¬±¸ ºÐ¾ß¿¡¼­ NGS ±â¼úÀÇ Çõ½Å °¡´É¼ºÀ» Àü ¼¼°èÀûÀ¸·Î º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù.

¼¼°è Â÷¼¼´ë ½ÃÄö½Ì(NGS) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð ÃßÁ¤ ¹× ¿¹Ãø, ÁúÀû/¾çÀû µ¿Çâ, ¿ªÇÐ, ºñÁî´Ï½º ÇÁ·¹ÀÓ¿öÅ©, °æÀï »óȲ, ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå Â÷¼¼´ë ½ÃÄö½Ì(NGS) ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå¿¡ °üÇÑ ÁÖ¿ä ÀλçÀÌÆ®

Á¦4Àå Â÷¼¼´ë ½ÃÄö½Ì(NGS) ½ÃÀå Àü¸Á

Á¦5Àå Â÷¼¼´ë ½ÃÄö½Ì(NGS) ½ÃÀå Àü·«

Á¦6Àå Â÷¼¼´ë ½ÃÄö½Ì(NGS) ½ÃÀå ±Ô¸ð

Á¦7Àå Â÷¼¼´ë ½ÃÄö½Ì(NGS) ½ÃÀå : À¯Çüº°

Á¦8Àå Â÷¼¼´ë ½ÃÄö½Ì(NGS) ½ÃÀå : Á¦Ç°º°

Á¦9Àå Â÷¼¼´ë ½ÃÄö½Ì(NGS) ½ÃÀå : ¼­ºñ½ºº°

Á¦10Àå Â÷¼¼´ë ½ÃÄö½Ì(NGS) ½ÃÀå : ±â¼úº°

Á¦11Àå Â÷¼¼´ë ½ÃÄö½Ì(NGS) ½ÃÀå : ¿ëµµº°

Á¦12Àå Â÷¼¼´ë ½ÃÄö½Ì(NGS) ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦13Àå Â÷¼¼´ë ½ÃÄö½Ì(NGS) ½ÃÀå : ±¸¼º¿ä¼Òº°

Á¦14Àå Â÷¼¼´ë ½ÃÄö½Ì(NGS) ½ÃÀå : ÇÁ·Î¼¼½ºº°

Á¦15Àå Â÷¼¼´ë ½ÃÄö½Ì(NGS) ½ÃÀå : ±â´É¼ºº°

Á¦16Àå Â÷¼¼´ë ½ÃÄö½Ì(NGS) ½ÃÀå : Áö¿ªº°

Á¦17Àå °æÀï »óȲ

Á¦18Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Next Generation Sequencing market is anticipated to expand from $14.5 billion in 2023 to $41.5 billion by 2033, exhibiting a CAGR of 11.1%.

The Next Generation Sequencing (NGS) market encompasses the advanced genomic sequencing technologies that enable rapid and precise DNA and RNA analysis. This market includes high-throughput sequencing platforms, reagents, software, and services, facilitating applications in personalized medicine, genetic research, and diagnostics. NGS technologies are pivotal in understanding complex genetic disorders, oncology, and infectious diseases, driving innovation and offering transformative solutions in healthcare and life sciences.

The Next Generation Sequencing (NGS) market is witnessing growth, driven by advancements in genomic research and personalized medicine. Among the segments, the consumables sub-segment, encompassing reagents and kits, is the top performer due to their recurrent usage and necessity in sequencing processes. Sequencing services emerge as the second-highest performing sub-segment, bolstered by the increasing outsourcing of sequencing tasks to specialized service providers. Regionally, North America leads the market, attributed to its well-established healthcare infrastructure and significant investments in genomic research. Europe follows as the second most lucrative region, benefiting from supportive government policies and a growing focus on precision medicine. Within countries, the United States stands out as the dominant player, while China is rapidly catching up, driven by its expanding biotech industry and substantial government funding for genomic initiatives. These dynamics underscore the transformative potential of NGS technologies across healthcare and research sectors globally.

Key Companies

Illumina, Thermo Fisher Scientific, Qiagen, BGI Genomics, Roche Diagnostics, Oxford Nanopore Technologies, Agilent Technologies, Pacific Biosciences, Bio- Rad Laboratories, Perkin Elmer, Genoox, Genomatix, Macrogen, Takara Bio, Genewiz, Novogene, Personalis, 10x Genomics, Fulgent Genetics, Strand Life Sciences, Genomic Innovators, Seq Tech Solutions, Next Gen Bio Labs, Precision Sequencing, Molecular Horizons, Gen Seq Dynamics, Helix Path Technologies, Bio Nexis Genomics, Future Seq Bio, Genome Insight, Seq Quest Labs, Advanced Genomic Systems, Pioneer Sequencing, Genomic Trailblazers, Nex Genomics, Innovative Gene Solutions, Seq Sphere Technologies, Genome Xplore, Genomic Frontier, Seq Vision

Research Scope

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1. Next Generation Sequencing Market Overview

2. Executive Summary

3. Premium Insights on the Market

4. Next Generation Sequencing Market Outlook

5. Next Generation Sequencing Market Strategy

6. Next Generation Sequencing Market Size

7. Next Generation Sequencing Market, by Type

8. Next Generation Sequencing Market, by Product

9. Next Generation Sequencing Market, by Services

10. Next Generation Sequencing Market, by Technology

11. Next Generation Sequencing Market, by Application

12. Next Generation Sequencing Market, by End User

13. Next Generation Sequencing Market, by Component

14. Next Generation Sequencing Market, by Process

15. Next Generation Sequencing Market, by Functionality

16. Next Generation Sequencing Market, by Region

17. Competitive Landscape

18. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â